Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data

被引:0
|
作者
Hamedi, Zahra
Lo, Andrea Yachee
Berkman, Jonathan David
Alesi, Erin R.
机构
[1] Virginia Commonwealth Univ Hlth Syst, Div Hematol Oncol & Palliat Care, Massey Comprehens Canc Ctr, Richmond, VA USA
[2] Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Richmond, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6022
引用
收藏
页数:1
相关论文
共 50 条
  • [21] First-line cetuximab plus platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE
    Le Tourneau, Christophe
    Ghiani, Massimo
    Cau, Maria Chiara
    Depenni, Roberta
    Ronzino, Graziana
    Bonomo, Pierluigi
    Montesarchio, Vincenzo
    Leo, Luigi
    Schulten, Jeltje
    Salmio, Satu
    Messinger, Diethelm
    Sbrana, Andrea
    Borcoman, Edith
    Ghi, Maria Grazia
    CANCER REPORTS, 2023, 6 (05)
  • [22] High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chauffert, Bruno
    Zhou, Yuedan
    Medjkoune, Liza
    Ouikene, Abdenour
    Galez, Agnes
    Belkhir, Farid
    Saint-Germain, Pierre
    Youssef, Ali
    Chehimi, Mohamad
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 13 - 20
  • [23] The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China
    Fan, Zongyu
    Hui, Rongrong
    Ju, Houyu
    Wu, Yunteng
    Ma, Xuhui
    Song, Hao
    Liu, Yang
    Rui, Mengyu
    Geng, Xinrong
    Zhao, Minqi
    Xin, Yingye
    Wei, Dongliang
    Ren, Guoxin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Outcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum-based chemotherapy with or without cetuximab in real-world practice
    Zupancic, Tina
    Zakotnik, Branko
    Kuhar, Cvetka Grasic
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (03)
  • [25] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Fushimi, Chihiro
    Baba, Daisuke
    Masubuchi, Tatsuo
    Yamazaki, Morio
    Kitani, Yosuke
    Kitajima, Tatsuya
    Tanaka, Junpei
    Hanyu, Kenji
    Tanaka, Naruhisa
    Miura, Kouki
    Tada, Yuichiro
    IN VIVO, 2020, 34 (05): : 2653 - 2657
  • [26] Simlukafusp a and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck
    Hansen, A. R.
    Gomez-Roca, C. A.
    Lolkema, M. P.
    Verlingue, L.
    Italiano, A.
    Spicer, J.
    Steeghs, N.
    Bauman, J. E.
    Fayette, J.
    Niu, J.
    Prenen, H.
    Dejardin, D.
    Boetsch, C.
    Kraxner, A.
    Evers, S.
    Vardar, T.
    Keshelava, N.
    Teichgraber, V.
    Bonomi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S805 - S805
  • [27] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
  • [28] The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis
    Kjems, Julie
    Laursen, Michael R. T.
    Kristensen, Claus A.
    Gothelf, Anita B.
    Bernsdorf, Mogens
    Specht, Lena
    Berthelsen, Anne K.
    Vogelius, Ivan R.
    Persson, Gitte F.
    Friborg, Jeppe
    ACTA ONCOLOGICA, 2023, 62 (09) : 1091 - 1095
  • [29] Real-world outcomes for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab
    Singh, P.
    You, M.
    Lubinga, S.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Real-world evidence of first-line cetuximab (CX) plus paclitaxel (PX) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Cirauqui Cirauqui, B.
    Martinez Trufero, J.
    Plana Serrahima, M.
    Garcia Castano, A.
    Rubio-Casadevall, J.
    Carral Maseda, A.
    Iglesias Docampo, L.
    Perez Segura, P.
    Ceballos Lenza, I.
    Gutierrez Calderon, V.
    Fuster Salva, J.
    Pena Alvarez, C.
    Arrazubi Arrula, V.
    del Barco Morillo, E.
    Chaves Conde, M.
    Martinez Galan, J.
    Duran Sanchez, M.
    Quiroga, V.
    Ortega, E.
    Mesia Nin, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S852 - S853